Ignite Creation Date:
2025-12-25 @ 1:34 AM
Ignite Modification Date:
2026-02-23 @ 6:25 AM
Study NCT ID:
NCT02163694
Status:
COMPLETED
Last Update Posted:
2025-02-19
First Post:
2014-05-19
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Phase 3 Randomized, Placebo-controlled Trial of Carboplatin and Paclitaxel With or Without Veliparib (ABT-888) in HER2-negative Metastatic or Locally Advanced Unresectable BRCA-associated Breast Cancer
Sponsor:
AbbVie
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-04-08
Start Date Type:
ACTUAL
Primary Completion Date:
2019-04-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-01-25
Completion Date Type:
ACTUAL
First Submit Date:
2014-05-19
First Submit QC Date:
None
Study First Post Date:
2014-06-16
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2022-03-11
Results First Submit QC Date:
None
Results First Post Date:
2022-04-04
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2020-04-06
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2025-02-18
Last Update Post Date:
2025-02-19
Last Update Post Date Type:
ACTUAL